Kurt D Deshayes
age ~63
from San Francisco, CA
- Also known as:
-
- Kurt Duaine Deshayes
- Kurt Dwaine Deshayes
- Kurt Te Deshayes
- Kurt Duaine Hayes
- Kurt D Hayes
- Deshayes Deshayes
- Phone and address:
-
138 Southwood Dr, San Francisco, CA 94112
415 469-8535
Kurt Deshayes Phones & Addresses
- 138 Southwood Dr, San Francisco, CA 94112 • 415 469-8535
- South San Francisco, CA
- Bowling Green, OH
- Los Angeles, CA
- 455 Vallejo St APT 303, San Francisco, CA 94133 • 415 747-2325
Work
-
Position:Professional/Technical
Us Patents
-
Inhibitors Of Iap
view source -
US Patent:7244851, Jul 17, 2007
-
Filed:Jul 5, 2005
-
Appl. No.:11/174784
-
Inventors:Frederick Cohen - San Francisco CA, US
Kurt Deshayes - San Francisco CA, US
Wayne J. Fairbrother - Burlingame CA, US
Bainian Feng - Foster City CA, US
John A. Flygare - Burlingame CA, US
Lewis J. Gazzard - Belmont CA, US
Vickie Hsiao-Wei Tsui - San Francisco CA, US -
Assignee:Genentech, Inc. - South San Francisco CA
-
International Classification:C07D 207/09
C07D 231/12
C07D 233/60
C07D 263/32
C07D 275/02
C07D 257/04
C07D 285/06 -
US Classification:548524, 548527, 5483561, 5483001, 548215, 548240, 548206, 548255, 5482626, 548125, 548127, 548250, 514422, 514403, 514397, 514374, 514378, 514372, 514359, 514383
-
Abstract:The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I:.
-
Method Of Inhibiting Insulin-Like Growth Factor-1 (Igf-1) By Igf-1-Antagonist Peptides
view source -
US Patent:7432244, Oct 7, 2008
-
Filed:Jun 23, 2006
-
Appl. No.:11/473753
-
Inventors:Kurt D. Deshayes - San Francisco CA, US
Henry B. Lowman - El Granada CA, US
Michelle L. Schaffer - Cambridge, GB
Sachdev S. Sidhu - San Francisco CA, US -
Assignee:Genentech, Inc. - South San Francisco CA
-
International Classification:A61K 38/30
C07K 14/65 -
US Classification:514 13, 4241301
-
Abstract:Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
-
Inhibitors Of Iap
view source -
US Patent:8110568, Feb 7, 2012
-
Filed:Mar 18, 2010
-
Appl. No.:12/727218
-
Inventors:Frederick Cohen - San Francisco CA, US
Kurt Deshayes - San Francisco CA, US
Wayne J. Fairbrother - Burlingame CA, US
Bainian Feng - Foster City CA, US
John A. Flygare - Burlingame CA, US
Lewis J. Gazzard - Belmont CA, US
Vickie Hsiao-Wei Tsui - San Francisco CA, US -
Assignee:Genentech, Inc. - South San Francisco CA
-
International Classification:A61K 31/55
A61K 31/4035
A61K 31/427
A61K 31/4155
A61K 31/433
A61K 31/40
A61K 31/4192
A61K 31/42
A61K 31/41
A61K 31/4245
A61K 31/4439
A61P 35/00 -
US Classification:51421206, 514417, 514365, 514407, 514361, 514427, 514359, 514380, 514381, 514364, 514342
-
Abstract:The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I:.
-
Heterocyclic Compounds And Methods Of Use
view source -
US Patent:8232273, Jul 31, 2012
-
Filed:Dec 17, 2009
-
Appl. No.:12/641141
-
Inventors:Jonathan Bayldon Baell - Bundoora, AU
Chinh Thien Bui - Balwyn North, AU
Peter Colman - East Melbourne, AU
Peter Czabotar - Melbourne, AU
Danette A. Dudley - Pacifica CA, US
Wayne J. Fairbrother - Burlingame CA, US
John A. Flygare - Burlingame CA, US
Guillaume Laurent Lessene - Coburg, AU
Chudi Ndubaku - San Francisco CA, US
George Nikolakopoulos - Thomastown, AU
Brad Edmund Sleebs - Reservoir, AU
Brian John Smith - Sunbury, AU
Keith Geoffrey Watson - Surry Hills, AU
Steven W. Elmore - Northbrook IL, US
Lisa A. Hasvold - Grayslake IL, US
Andrew M. Petros - Mundelein IL, US
Andrew J. Souers - Evanston IL, US
Zhi-Fu Tao - Gurnee IL, US
Le Wang - Vernon Hills IL, US
Xilu Wang - Grayslake IL, US
Kurt Deshayes - San Francisco CA, US -
Assignee:Genentech, Inc. - South San Francisco CA
Abbott Laboratories - Abbott Park IL
The Walter and Eliza Hall Institute of Medical Research - Victoria -
International Classification:A61K 31/5377
C07D 413/14 -
US Classification:5142338, 544111
-
Abstract:In one aspect, the present invention provides for a compound of Formula I.
-
Igf Antagonist Peptides
view source -
US Patent:20030092631, May 15, 2003
-
Filed:Mar 13, 2002
-
Appl. No.:10/098093
-
Inventors:Kurt Deshayes - San Francisco CA, US
Henry Lowman - El Granada CA, US
Michelle Schaffer - Cambridge, GB
Sachdev Sidhu - San Francisco CA, US -
Assignee:GENENTECH, INC.
-
International Classification:A61K038/10
C07K007/08 -
US Classification:514/014000, 530/326000
-
Abstract:Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
-
Compositions And Methods For Enhancing Apoptosis
view source -
US Patent:20040171554, Sep 2, 2004
-
Filed:Feb 7, 2003
-
Appl. No.:10/364645
-
Inventors:Kurt Deshayes - San Francisco CA, US
Wayne Fairbrother - Burlingame CA, US
John Flygare - Burlingame CA, US
Matthew Franklin - San Francisco CA, US
Saloumeh Fischer - Casto Valley CA, US
Domagoj Vucic - San Francisco CA, US -
Assignee:GENENTECH, INC.
-
International Classification:A61K038/08
C07K007/06 -
US Classification:514/016000, 530/328000
-
Abstract:The present invention is directed to compositions of matter useful for the enhancement of apoptosis in mammals and to methods of using those compositions of matter for the same.
-
Igf Antagonist Peptides
view source -
US Patent:20060149033, Jul 6, 2006
-
Filed:Feb 1, 2006
-
Appl. No.:11/346079
-
Inventors:Kurt Deshayes - San Francisco CA, US
Henry Lowman - El Granada CA, US
Michelle Schaffer - Cambridge, GB
Sachdev Sidhu - San Francisco CA, US -
International Classification:C07K 7/08
-
US Classification:530327000, 530328000
-
Abstract:Peptides are provided that antagonize the interaction of IGF-1 with its binding proteins, insulin receptor, and IGF receptor. These IGF antagonist peptides are useful in treating disorders involving IGF-1 as a causative agent, such as, for example, various cancers.
-
Inhibitors Of Iap
view source -
US Patent:20070299052, Dec 27, 2007
-
Filed:Apr 23, 2007
-
Appl. No.:11/739030
-
Inventors:Frederick Cohen - San Francisco CA, US
Kurt Deshayes - San Francisco CA, US
Wayne Fairbrother - Burlingame CA, US
Bainian Feng - Foster City CA, US
John Flygare - Burlingame CA, US
Lewis Gazzard - Belmont CA, US
Vickie Tsui - San Francisco CA, US -
Assignee:Genentech, Inc. - South San Francisco CA
-
International Classification:A61K 31/55
A61K 31/351
A61K 31/40
A61K 31/41
A61P 35/00
C07D 207/30
C07D 223/14
C07D 277/02
C07D 309/02
C12N 9/00
C12N 5/00
C07D 285/06
C07D 231/02
C07D 221/00
A61P 43/00
A61K 31/415
A61K 31/426
A61K 31/445 -
US Classification:514212060, 435184000, 435375000, 514315000, 514361000, 514371000, 514407000, 514427000, 514459000, 540521000, 546184000, 548127000, 548192000, 548364100, 548561000, 549356000
-
Abstract:The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein X, Y, A, R, R, R, R, R′, R, R′, Rand R′ are as described herein.
Resumes
Private Consultant
view sourceLocation:
South San Francisco, CA
Industry:
Biotechnology
Work:
Kurt Deshayes
Private Consultant
Chemical Biology Consultants
Private Consultant
Private Consultant
Chemical Biology Consultants
Private Consultant
Education:
University of Chicago 1983 - 1988
Doctorates, Doctor of Philosophy, Organic Chemistry Carleton College 1979 - 1983
Bachelors, Bachelor of Arts, Chemistry
Doctorates, Doctor of Philosophy, Organic Chemistry Carleton College 1979 - 1983
Bachelors, Bachelor of Arts, Chemistry
Skills:
Drug Design
Cell Biology
Chemistry
Organic Synthesis
Biotechnology
Cell
Pcr
Cell Culture
Drug Discovery
Molecular Biology
Lifesciences
Oncology
Drug Development
Mass Spectrometry
Cancer
Medicinal Chemistry
Protein Expression
Protein Purification
Biochemistry
Pharmaceutical Industry
Technology Transfer
Protein Chemistry
Cell Biology
Chemistry
Organic Synthesis
Biotechnology
Cell
Pcr
Cell Culture
Drug Discovery
Molecular Biology
Lifesciences
Oncology
Drug Development
Mass Spectrometry
Cancer
Medicinal Chemistry
Protein Expression
Protein Purification
Biochemistry
Pharmaceutical Industry
Technology Transfer
Protein Chemistry
Senior Project Manager
view sourceLocation:
San Francisco, CA
Industry:
Management Consulting
Work:
Lawrence Berkeley National Laboratory
Senior Project Manager
Senior Project Manager
Education:
University of Phoenix 1972 - 1976
Senior Scientist
view sourceLocation:
San Francisco, CA
Industry:
Biotechnology
Work:
Genentech
Senior Scientist
Senior Scientist
Get Report for Kurt D Deshayes from San Francisco, CA, age ~63